Currant, ribes nigrum, ext.
CAS 68606-81-5
Currant, ribes nigrum, ext. (CAS 68606-81-5) is a pharmaceutical compound with 0 bioactivity targets and 16 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Currant, ribes nigrum, ext. is linked to DTXSID201027851 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Currant, ribes nigrum, ext. used for in pharmaceutical contexts?
Currant, ribes nigrum, ext. (CAS 68606-81-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Currant, ribes nigrum, ext.?
Currant, ribes nigrum, ext. has 16 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Arthritis, Arthropathy, Blood cholesterol increased, Device dislocation, Glucose tolerance impaired. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Currant, ribes nigrum, ext. also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Ribes Nigrum Seed Oil with EU status "permitted".
What clinical phase is Currant, ribes nigrum, ext. in?
No phase 1-4 clinical development badge is rendered for Currant, ribes nigrum, ext. because the matched compound identifier rows do not contain a max-phase value.